News
Stay up to date on the latest crypto trends with our expert, in-depth coverage.
1Bitget UEX Daily | Iran Denies Direct Talks; Oil Price Back Above $100; Nasdaq 100 Rule Change May Open Door for SpaceX (March 31, 2026)2Bitcoin data points to ‘rare’ trading setup for relief rally to $71K3Iran's Potential Blockade of the Strait of Hormuz: Approaching April 6 and Growing Market Anxiety
Reddit Drops 4.7% Amid Surging Bets: Is This a Prelude to a Rebound or a Breakout?
101 finance·2026/03/19 19:15
TAC (TAC) fluctuates 42.4% in 24 hours: trading volume surges 367% as low liquidity amplifies movements
Bitget Pulse·2026/03/19 19:14
Live Nation CEO Michael Rapino, standing up for his company, becomes central figure in antitrust court case
101 finance·2026/03/19 19:12
RPD Fund Makes Major $100 Million Investment in Nice Stock as AI Concerns Loom
101 finance·2026/03/19 19:12
ALDX Jumps More Than 21% During the Day: What’s Driving This Biotech Rally?
101 finance·2026/03/19 19:12
OCC Surges 11% Without Clear Catalyst — Is This a Breakout or a False Signal?
101 finance·2026/03/19 19:09
RBC says its focus on AI is paying dividends
101 finance·2026/03/19 19:09
USD/CHF Price Forecast: Rejected at 200-day SMA, drops towards 0.7900
101 finance·2026/03/19 19:09
ECB's Digital Euro: Flow of Costs, Pilot Activity, and Legislative Catalyst
101 finance·2026/03/19 19:06
TotalEnergies Jumps More Than 3.5%—Will This Surge Keep Fueling the Energy Leader’s Growth?
101 finance·2026/03/19 19:06
Flash
12:48
Reuters Significantly Raises 2026 Average U.S. Crude Oil Price ForecastBlockBeats news, on March 31, according to a Reuters survey, the average price of US crude oil in 2026 is expected to be $76.78 per barrel, while the forecast in February was $60.38; the average price of Brent crude oil in 2026 is expected to be $82.85 per barrel, whereas the February forecast was $63.85. (Golden Ten Data)
12:46
Biopharmaceutical company Tarsus Pharmaceuticals, Inc. announced that its innovative oral tablet TP-05 (lotilaner) for the potential prevention of Lyme disease has dosed the first subject in the Phase 2 clinical trial "Calliope".The study aims to evaluate the potential application of this experimental drug, based on the lotilaner ingredient, in the field of disease prevention.
12:44
Buffett Says Berkshire Hathaway Bought $17 Billion in Treasury Bonds This Week Buffett stated that Berkshire Hathaway purchased $17 billion in Treasury bonds this week. He also mentioned that if the market experiences a significant decline, Berkshire Hathaway will utilize its cash.
News